BIOMAT Database Logo BIOMAT Database Logo

[Pharmacological aspects of calcium channel blockers: therapeutic implications]. 1987

J G Mill, and D V Vassallo, and E C Vasquez

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

J G Mill, and D V Vassallo, and E C Vasquez
Pharmacological aspects of calcium channel blockers.
January 1997, Cardiovascular drugs and therapy,
J G Mill, and D V Vassallo, and E C Vasquez
New uses for calcium channel blockers. Therapeutic implications.
December 1993, Drugs,
J G Mill, and D V Vassallo, and E C Vasquez
Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
November 1987, Journal of clinical pharmacology,
J G Mill, and D V Vassallo, and E C Vasquez
Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences.
September 2004, Journal of hypertension,
J G Mill, and D V Vassallo, and E C Vasquez
Selected pharmacological properties of calcium channel blockers.
July 1985, The Alabama journal of medical sciences,
J G Mill, and D V Vassallo, and E C Vasquez
Anaesthetic implications of calcium channel blockers.
July 1985, Canadian Anaesthetists' Society journal,
J G Mill, and D V Vassallo, and E C Vasquez
Therapeutic uses of calcium channel blockers.
April 1983, American family physician,
J G Mill, and D V Vassallo, and E C Vasquez
[Pharmacological properties and use of calcium channel blockers].
January 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J G Mill, and D V Vassallo, and E C Vasquez
[Differential pharmacological aspects between voltage-gated sodium channel blockers: implications in clinical practice].
January 2021, Atencion primaria,
J G Mill, and D V Vassallo, and E C Vasquez
[Pharmacology--new therapy. Calcium channel blockers: new aspects of therapeutic use of diltiazem].
January 1992, Srpski arhiv za celokupno lekarstvo,
Copied contents to your clipboard!